Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenza Mamouni
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy
European Oncology and Haematology
Oncology
Hematology
Outcome of Combination Chemotherapy With Docetaxel, Estramustine Phosphate, and Carboplatin After Docetaxel and Prednisolone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Journal of Cancer Therapy
Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer
Urologic Clinics of North America
Urology
‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Case Report: Responses to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer After Extensive Docetaxel Treatment
Clinical Genitourinary Cancer
Oncology
Urology
The Effects of Clozapine on Behavioural Responses to the Selective ‘D1-Like’ Dopamine Receptor Agonist, a 68930, and to the Selective ‘D2-Like’ Agonist, RU 24213
British Journal of Pharmacology
Pharmacology
Combined Effect of Sodium Selenite and Docetaxel on PC3 Metastatic Prostate Cancer Cell Line
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer With Bone Metastases
Clinical Cancer Research
Cancer Research
Oncology
